<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04894136</url>
  </required_header>
  <id_info>
    <org_study_id>1906</org_study_id>
    <nct_id>NCT04894136</nct_id>
  </id_info>
  <brief_title>Reproductive and Obstetric Outcomes in TESE-ICSI Cycles for Azoospermia</brief_title>
  <acronym>AZOOCOMES</acronym>
  <official_title>Reproductive and Obstetric Outcomes in TESE-ICSI Cycles: a Comparison Between Obstructive and Non-obstructive Azoospermia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istituto Clinico Humanitas</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istituto Clinico Humanitas</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A comparison of reproductive and obstetrical outcomes is retrospectively performed among&#xD;
      couples that underwent ICSI-TESE cycles for obstructive and non obstructive azoospermia&#xD;
      between January 2001 and December 2019.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Azoospermia affects almost 20% of all infertile males and It can be divided into obstructive&#xD;
      azoospermia (OA) and nonobstructive azoospermia (NOA). Assisted fertilization with testicular&#xD;
      sperm extraction (TESE) and intracytoplasmatic sperm injection (ICSI) has been successfully&#xD;
      applied for its treatment.&#xD;
&#xD;
      Review of the literature shows that there is a lack of consensus about reproductive outcomes&#xD;
      between men with OA and NOA. No study has ever investigated differences in obstetrical&#xD;
      outcomes between these two groups before.&#xD;
&#xD;
      The objective of this study is to retrospectively determine differences in reproductive and&#xD;
      obstetrical outcomes among couples that underwent ICSI-TESE cycles for obstructive and non&#xD;
      obstructive azoospermia.&#xD;
&#xD;
      The primary outcomes that will be investigated include:&#xD;
&#xD;
        -  Reproductive outcomes: pregnancy rate, live birth rate (LBR) and abortion rate.&#xD;
&#xD;
        -  Obstetrical outcomes: twinning rate, gestational age, prematurity rate, birth weight,&#xD;
           cesarean section rate and the rate of the main obstetrical complication, such as&#xD;
           pre-eclampsia, gestational hypertension, intrauterine growth restriction (IUGR).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2001</start_date>
  <completion_date type="Actual">December 31, 2019</completion_date>
  <primary_completion_date type="Actual">December 31, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Live birth rate (LBR)</measure>
    <time_frame>20 years (2001-2019)</time_frame>
    <description>Rate of delivery of a living baby after at least 22 weeks of gestation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pregnancy rate</measure>
    <time_frame>20 years (2001-2019)</time_frame>
    <description>Total number of pregnancies including live births, abortions and fetal death</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Abortion rate</measure>
    <time_frame>20 years (2001-2019)</time_frame>
    <description>Proportion of clinical pregnancies who failed to continue beyond 22 weeks of gestation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Maternal complications rate</measure>
    <time_frame>20 years (2001-2019)</time_frame>
    <description>Incidence of the obstetric complications, such as pre-eclampsia, gestational hypertension, placenta previa and placental abruption, intrauterine growth restriction.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Gestational age</measure>
    <time_frame>20 years (2001-2019)</time_frame>
    <description>Mean gestational age of the pregnancies considered (written with both weeks and days)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Prematurity rate</measure>
    <time_frame>20 years (2001-2019)</time_frame>
    <description>Rate of pregnancies lasted less than 37 weeks and 0 days</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Twinning rate</measure>
    <time_frame>20 years (2001-2019)</time_frame>
    <description>Rate of twin deliveries out of the total number of deliveries</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cesarean section rate</measure>
    <time_frame>20 years (2001-2019)</time_frame>
    <description>Rate of cesarean section deliveries out of the total number of deliveries</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Birth weight</measure>
    <time_frame>20 years (2001-2019)</time_frame>
    <description>Mean birth weight of the neonates written in grams.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">520</enrollment>
  <condition>Obstructive Azoospermia</condition>
  <condition>Non-obstructive Azoospermia</condition>
  <condition>Obstetric Complication</condition>
  <arm_group>
    <arm_group_label>ICSI-TESE cycles for obstructive azoospermia</arm_group_label>
    <description>Couples who underwent ICSI-TESE cycles for obstructive azoospermia between January 2001 and December 2019 at Humanitas Fertility Center</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ICSI-TESE cycles for nonobstructive azoospermia</arm_group_label>
    <description>Couples who underwent ICSI-TESE cycles for nonobstructive azoospermia between January 2001 and December 2019 at Humanitas Fertility Center</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ICSI-TESE; embryo-transfer</intervention_name>
    <description>The sperm injected into the cytoplasm of an oocyte (Intracytoplasmatic Sperm Injection) is obtained by testicular extraction. Ultrasound guided transvaginal embryo transfer.</description>
    <arm_group_label>ICSI-TESE cycles for nonobstructive azoospermia</arm_group_label>
    <arm_group_label>ICSI-TESE cycles for obstructive azoospermia</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study database will include all the couples who underwent ICSI-TESE cycles between&#xD;
        January 2001 and December 2019 at Humanitas Fertility Center after ICSI-TESE for&#xD;
        obstructive and nonobstructive azoospermia.&#xD;
&#xD;
        ICSI-TESE cycles not reaching the stage of oocyte retrieval will be excluded.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria for obstructive azoospermia group:&#xD;
&#xD;
          -  infertility&#xD;
&#xD;
          -  diagnosis of obstructive azoospermia&#xD;
&#xD;
          -  ICSI-TESE cycles&#xD;
&#xD;
        Inclusion Criteria for non-obstructive azoospermia group:&#xD;
&#xD;
          -  infertility&#xD;
&#xD;
          -  diagnosis of non-obstructive azoospermia&#xD;
&#xD;
          -  ICSI-TESE cycles&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Sperm donation&#xD;
&#xD;
          -  Use of ejaculated sperm&#xD;
&#xD;
          -  Couples who underwent pre-implantation genetic testing&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <reference>
    <citation>Bocca S, Moussavi V, Brugh V, Morshedi M, Stadtmauer L, Oehninger S. ICSI outcomes in men undergoing TESE for azoospermia and impact of maternal age. Andrologia. 2017 Mar;49(2). doi: 10.1111/and.12617. Epub 2016 May 20.</citation>
    <PMID>27198124</PMID>
  </reference>
  <reference>
    <citation>He X, Cao Y, Zhang Z, Zhao J, Wei Z, Zhou P, Cong L. Spermatogenesis affects the outcome of ICSI for azoospermic patients rather than sperm retrieval method. Syst Biol Reprod Med. 2010 Dec;56(6):457-64. doi: 10.3109/19396368.2010.513078. Epub 2010 Oct 14.</citation>
    <PMID>20942727</PMID>
  </reference>
  <reference>
    <citation>La Sala GB, Valli B, Leoni S, Pescarini M, Martino F, Nicoli A. Testicular sperm aspiration (TESA) in 327 ICSI cycles. Int J Fertil Womens Med. 2006 Jul-Aug;51(4):177-82.</citation>
    <PMID>17184103</PMID>
  </reference>
  <reference>
    <citation>Palermo GD, Schlegel PN, Hariprashad JJ, Erg√ºn B, Mielnik A, Zaninovic N, Veeck LL, Rosenwaks Z. Fertilization and pregnancy outcome with intracytoplasmic sperm injection for azoospermic men. Hum Reprod. 1999 Mar;14(3):741-8.</citation>
    <PMID>10221707</PMID>
  </reference>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>April 16, 2021</study_first_submitted>
  <study_first_submitted_qc>May 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 20, 2021</study_first_posted>
  <last_update_submitted>May 16, 2021</last_update_submitted>
  <last_update_submitted_qc>May 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Reproductive outcomes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Azoospermia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

